Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.

@article{Sverrisdottir2004BoneMD,
  title={Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.},
  author={Asgerdur Sverrisdottir and Tommy Fornander and Hans Jacobsson and Eva von Schoultz and Lars Erik Rutqvist},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2004},
  volume={22 18},
  pages={3694-9}
}
PURPOSE To examine the effects on bone mineral density of 2 years of treatment with a luteinizing hormone-releasing hormone (LHRH) agonist alone or in combination with tamoxifen or tamoxifen alone in premenopausal breast cancer. PATIENTS AND METHODS We recruited 89 women from two centers in Stockholm participating in a randomized multicenter trial of three different endocrine approaches in the adjuvant setting (Zoladex in Premenopausal Patients Trial). The women were assigned to receive the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

Similar Papers

Loading similar papers…